Intravenous immunoglobulin therapy for autoimmune diseases, Autoimmunity, vol.42, pp.553-560, 2009. ,
Intravenous immunoglobulin therapy in rheumatic diseases, Nat. Rev. Rheumatol, vol.7, pp.349-359, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455562
Intravenous immunoglobulin in neurology-mode of action and clinical efficacy, Nat. Rev. Neurol, vol.11, pp.80-89, 2015. ,
Kawasaki disease: an evolving paradigm, Autoimmun. Rev, vol.14, pp.703-709, 2015. ,
Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders, Trends Pharmacol. Sci, vol.34, pp.445-457, 2013. ,
The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders, J. Allergy Clin. Immunol, vol.127, pp.315-323, 2011. ,
What is the contents of the magic draft IVIg?, Autoimmun. Rev, vol.7, pp.435-439, 2008. ,
Modulation of the cellular immune system by intravenous immunoglobulin, Trends Immmunol, vol.29, pp.608-615, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455606
Intravenous immune globulin in autoimmune and inflammatory diseases, N. Engl. J. Med, vol.367, pp.2015-2040, 2012. ,
Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review, Autoimmun. Rev, vol.13, pp.1182-1188, 2014. ,
Identification of a receptor required for the anti-inflammatory activity of IVIG, Proc. Natl. Acad. Sci. USA 105, pp.19571-19578, 2008. ,
A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?, Blood, vol.109, pp.155-158, 2007. ,
Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells, J. Allergy Clin. Immunol, vol.133, pp.181-188, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-00926676
Intravenous immunoglobulin a natural regulator of immunity and inflammation, Transplantation, vol.88, pp.1-6, 2009. ,
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?, Nat. Rev. Immunol, vol.13, pp.176-189, 2013. ,
Intravenous immunoglobulin-induced IL-33 is insufficient to mediate basophil expansion in autoimmune patients, Sci. Rep, vol.4, p.5672, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01358914
Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils, J. Immunol, vol.192, pp.5031-5038, 2014. ,
Immunomodulation by intravenous immunoglobulin: role of regulatory T cells, J. Clin. Immunol, vol.30, issue.1, pp.4-8, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455581
Tregitope update: mechanism of action parallels IVIg, Autoimmun. Rev, vol.12, pp.436-443, 2013. ,
Inhibition of FcgammaR-mediated phagocytosis by IVIg is independent of IgG-Fc sialylation and FcgammaRIIb in human macrophages, Blood, vol.124, pp.3709-3718, 2014. ,
Molecular and immunological biomarkers to predict IVIg response, Trends Mol. Med, vol.21, pp.145-147, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01117084
Pharmacological and clinical aspects of heme oxygenase, Pharmacol. Rev, vol.60, pp.79-127, 2008. ,
Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation, J. Clin. Invest, vol.117, pp.438-447, 2007. ,
Heme oxygenase-1-derived carbon monoxide enhances the host defense response to microbial sepsis in mice, J. Clin. Invest, vol.118, pp.239-247, 2008. ,
Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in NOD mice, Diabetes, vol.56, pp.1240-1247, 2007. ,
Heme oxygenase: a novel target for the modulation of the inflammatory response, Nat. Med, vol.2, pp.87-90, 1996. ,
Mycobacterium tuberculosis senses host-derived carbon monoxide during macrophage infection, Cell Host Microbe, vol.3, pp.323-330, 2008. ,
Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production, J. Immunol, vol.172, pp.4744-4751, 2004. ,
Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency, J. Clin. Invest, vol.103, pp.129-135, 1999. ,
Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor-1, Am. J. Pathol, vol.171, pp.1904-1914, 2007. ,
Heme oxygenase-1 is not required for mouse regulatory T cell development and function, Int. Immunol, vol.19, pp.11-18, 2007. ,
Heme oxygenase-1: unleashing the protective properties of heme, Trends Immunol, vol.24, pp.449-455, 2003. ,
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway, Nat. Med, vol.6, pp.422-428, 2000. ,
Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes, J. Immunol, vol.181, pp.6730-6737, 2008. ,
, Scientific RepoRts |, vol.6, 19592.
Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression, Blood, vol.106, pp.1694-1702, 2005. ,
Carbon monoxide inhibits TLR-induced dendritic cell immunogenicity, J. Immunol, vol.182, pp.1877-1884, 2009. ,
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin, Blood, vol.101, pp.758-765, 2003. ,
Intravenous immunoglobulin treatment in humans suppresses dendritic cell function via stimulation of IL-4 and IL-13 production, J. Immunol, vol.192, pp.5625-5634, 2014. ,
Induction of PD-L1 on monocytes: a new mechanism by which IVIg inhibits mixed lymphocyte reactions, Immunobiology, vol.219, pp.687-694, 2014. ,
Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells, Blood, vol.122, pp.1419-1427, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455532
Intravenous gammaglobulin inhibits encephalitogenic potential of pathogenic T cells and interferes with their trafficking to the central nervous system, implicating sphingosine-1 phosphate receptor 1-mammalian target of rapamycin axis, J. Immunol, vol.190, pp.4535-4541, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455535
Protection in antibody-and T cell-mediated autoimmune diseases by antiinflammatory IgG Fcs requires type II FcRs, Proc. Natl. Acad. Sci. USA, vol.112, pp.2385-2394, 2015. ,
Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin, J. Allergy Clin. Immunol, vol.127, pp.823-830, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455567
Inhibitory effect of IVIG on IL-17 production by Th17 cells is independent of anti-IL-17 antibodies in the immunoglobulin preparations, J. Clin. Immunol, vol.33, pp.62-66, 2013. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455547
Intravenous immunoglobulin-mediated expansion of regulatory T cells in autoimmune patients is associated with increased prostaglandin E2 levels in the circulation, Cell. Mol. Immunol, vol.12, pp.650-652, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455500
Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function, J. Immunol, vol.179, pp.5571-5575, 2007. ,
Intravenous immunoglobulin expands regulatory T cells in autoimmune rheumatic disease, J. Rheumatol, vol.39, pp.450-451, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455584
Dendritic cell immunoreceptor: a novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells, J. Allergy Clin. Immunol, vol.133, pp.853-863, 2014. ,
Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin, Circulation, vol.107, pp.911-916, 2003. ,
Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts, J. Exp. Med, vol.203, pp.2377-2389, 2006. ,
FOXP3+ regulatory T cells in the human immune system, Nat. Rev. Immunol, vol.10, pp.490-500, 2010. ,
Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression, Biochem. Biophys. Res. Commun, vol.327, pp.1066-1071, 2005. ,
Pivotal Advance: Heme oxygenase 1 expression by human CD4+ T cells is not sufficient for their development of immunoregulatory capacity, J. Leukoc. Biol, vol.87, pp.193-202, 2010. ,
Suppression by CD4+ CD25+ regulatory T cells is dependent on expression of heme oxygenase-1 in antigenpresenting cells, Am. J. Pathol, vol.173, pp.154-160, 2008. ,
Heme oxygenase-1 exerts a protective role in ovalbumin-induced neutrophilic airway inflammation by inhibiting Th17 cell-mediated immune response, J. Biol. Chem, vol.288, pp.34612-34626, 2013. ,
Eye-mediated induction of specific immune tolerance to encephalitogenic antigens, CNS Neurosci. Ther, vol.19, pp.503-510, 2013. ,
The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment, Handb. Clin. Neurol, vol.122, pp.173-189, 2014. ,
IVIg for relapsing-remitting multiple sclerosis: promises and uncertainties, Trends Pharmacol. Sci, vol.36, pp.419-421, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01155485
Comparison of different IVIg preparations on IL-17 production by human Th17 cells, Autoimmun. Rev, vol.10, pp.809-810, 2011. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455563
Human B cells induce dendritic cell maturation and favour Th2 polarization by inducing OX-40 ligand, Nat. Commun, vol.5, p.4092, 2014. ,
URL : https://hal.archives-ouvertes.fr/inserm-02455506